LGBT Cancer Project

Therapeutic Areas: Oncology

Polyps Clinical Trials

A listing of Polyps medical research trials actively recruiting patient volunteers. Click on the closest city to find more detailed information on a research study in your area.

 

California

UPDATED

Fresno California 93720

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Long Beach California 90720

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Orange California 92868

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Stockton California 95207

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

UPDATED

Walnut Creek California 94598

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Colorado

Centennial Colorado 80112

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

UPDATED

Colorado Springs Colorado 80909

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

UPDATED

Denver Colorado 80230

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Connecticut

New Haven Connecticut 06511

A clinical research study for the treatment of Healthy or Chronic Rhinosinusitis With Nasal Polyps

UPDATED

New Haven Connecticut 06519

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Florida

Jacksonville Florida FL 32224

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm

Indiana

Indianapolis Indiana IN 46290

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm

Kansas

Kansas City Kansas KS 66160

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm

Massachusetts

Boston Massachusetts 02210

A clinical trial to evaluate treatments using VAS questionnaire, SNOT-22 questionnaire and Data capture app for patients with Polyps, Nasal

Minnesota

Minneapolis Minnesota 55404

A clinical research study for the treatment of Healthy or Chronic Rhinosinusitis With Nasal Polyps

Minneapolis Minnesota 55402

A clinical research study for the treatment of Healthy or Chronic Rhinosinusitis With Nasal Polyps

Rochester Minnesota 55905

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

St. Paul Minnesota 55114

A clinical research study for the treatment of Healthy or Chronic Rhinosinusitis With Nasal Polyps

Missouri

UPDATED

Kansas City Missouri 64115

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

St. Louis Missouri 63141

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

North Carolina

UPDATED

North Charleston North Carolina 29420

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Ohio

Dublin Ohio 43016

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Oklahoma

Tulsa Oklahoma 74136

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

South Carolina

UPDATED

Orangeburg South Carolina 29118

A Phase 3 clinical study for patients with Polyps, Nasal

Utah

UPDATED

Salt Lake City Utah 84132

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Vermont

White River Junction Vermont 05009

Patients are needed to participate in a clinical research study of Resolution II clip to evaluate Colon Polyps

Virginia

UPDATED

Fairfax Virginia 22030

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Norfolk Virginia 23507

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Washington

UPDATED

Bellevue Washington 98225

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Wisconsin

UPDATED

Milwaukee Wisconsin 53219

A clinical trial to evaluate treatments using Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for patients with Nasal Polyps

Australia

UPDATED

Clayton Victoria 3169

A Phase 3 clinical study for patients with Polyps, Nasal

Bulgaria

Plovdiv 4002

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Sofia 1527

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Sofia 1606

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Canada

UPDATED

London Ontario N6A 4V2

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Montreal Quebec H2W 1T8

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Montreal Quebec H3G 1L5

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Québec G1S 4L8

A Phase 3 clinical study for patients with Polyps, Nasal

Czechia

Hradec Kralove 50005

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Pardubice 53203

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Plzen 30599

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Praha 2 12808

A clinical research study of Dupilumab SAR231893 (REGN668), Placebo and Mometasone furoate nasal spray for the treatment of Nasal Polyps

Germany

UPDATED

Berlin 13353

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Dresden Sachsen 01307

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Dresden Sachsen 01139

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Muenchen Bayern 81675

A Phase 3 clinical study for patients with Polyps, Nasal

UPDATED

Wiesbaden Hessen 65183

A Phase 3 clinical study for patients with Polyps, Nasal

Israel

Haifa

Patients are needed to participate in a clinical research study of G-EYE™ Colonoscopy and Standard Colonoscopy to evaluate Adenoma, Polyps or Colorectal Cancer

Italy

Milan

Safety Study of SIC 8000 in Subjects Undergoing Endoscopic Mucosal Resection (EMR) of Colonic Lesions Equal to or Larger Than 2 cm